Identification of biorelevant dissolution media to assess biopharmaceutical performance of erlotinib formulation with enhanced bioavailability using physiologybased pharmacokinetic modeling. (2022). Asian Journal of Pharmaceutics (AJP), 16(2). https://doi.org/10.22377/ajp.v16i2.4389